Analysis of drug therapy in a patient with pulmonary infection secondary to suppurative thrombophlebitis
10.12206/j.issn.1006-0111.202107045
- VernacularTitle:1例化脓性血栓静脉炎继发肺部感染患者的药物治疗分析
- Author:
Runan QU
1
,
2
;
Junqin MAO
2
;
Rujuan XIN
3
;
He ZHANG
2
;
An GAO
3
Author Information
1. Shanghai General Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200080, China
2. Jiading Branch of Shanghai General Hospital, Shanghai 201803, China.
3. Shanghai General Hospital Affiliated to Shanghai Jiao Tong University, Shanghai 200080, China.
- Keywords:
suppurative thrombophlebitis;
metastatic infection;
vancomycin;
therapeutic drug monitoring;
anticoagulation
- From:
Journal of Pharmaceutical Practice
2022;40(2):171-174
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the role of pharmaceutical care in the treatment of patients with pulmonary infection secondary to suppurative thrombophlebitis. Methods The treatment of a patient diagnosed with pulmonary metastatic infection secondary to suppurative thrombophlebitis and the whole process of clinical pharmacists participating in the monitoring were analyzed retrospectively. The use of antibiotics was evaluated, and the experience of coagulation management in suppurative thrombophlebitis was explored. Results Based on the infection site, characteristics of septic thrombus, monitoring of vancomycin blood concentration, pharmacokinetics and pharmacodynamics characteristics of antibiotics, clinical pharmacists provided comprehensive pharmaceutical services for clinicians and patients in terms of anti-infection scheme adjustment, optimization of vancomycin individualized treatment, anticoagulant timing. Patient’s systemic infection and septic thrombus can be effectively controlled and which promotes the treatment of patients with suppurative thrombophlebitis. Conclusion Clinical pharmacists can play an important role in the treatment team of severe patients to improve the rational use of antibiotics.
